Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹52 Cr
P/E Ratio
28.38
P/B Ratio
1.24
Industry P/E
43.02
Debt to Equity
0
ROE
3.66 %
ROCE
5.35 %
Div. Yield
1.5 %
Book Value
42.86
EPS
1.88
CFO
₹28.94 Cr
EBITDA
₹23.07 Cr
Net Profit
₹8.12 Cr
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Sandu Pharma
| -6.90 | 1.18 | 0.55 | -15.61 | -10.05 | 23.15 | 6.88 |
|
BSE Healthcare
| -4.95 | 1.92 | -0.50 | 24.13 | 20.27 | 23.08 | 9.93 |
|
BSE Small Cap
| -10.08 | 4.17 | -3.87 | 5.97 | 18.98 | 35.50 | 15.85 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Sandu Pharma
| -19.56 | 1.79 | -4.63 | 68.96 | 198.94 | -41.42 | -24.29 |
|
BSE Small Cap
| 29.04 | 47.52 | -1.80 | 62.77 | 32.11 | -6.85 | -23.41 |
|
BSE Healthcare
| 43.09 | 36.97 | -12.10 | 20.87 | 61.45 | -3.55 | -5.89 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
|---|---|---|---|---|
| 2,254.70 | 5,605.22 | 80.99 | 43.52 | |
| 352.35 | 423.96 | 622.56 | 1.68 | |
| 156.40 | 246.25 | 39.05 | 99.24 | |
| 144.65 | 152.08 | 76.8 | 4.82 |
No Review & Analysis are available.
Sandu Pharmaceuticals Limited manufactures and markets ayurvedic medicines under the SANDU brand in India and internationally. The company offers medicines in the areas of cardiovascular, endocrine, digestive, genito-urinary, muscular-skeletal,... nervous, male reproductive, and respiratory system. It also provides medicines for gynecological; nutrition; skin; and ear, nose, and throat disorders. The company was founded in 1899 and is based in Mumbai, India. Read more
Incorporated
1985
Chairman
Balram Viswanathan
Managing Director
--
Headquarters
Bardez, Goa
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The total asset value of Sandu Pharmaceuticals Ltd stood at ₹ 55 Cr as on 31-Dec-24
The share price of Sandu Pharmaceuticals Ltd is ₹53.31 (BSE) as of 24-Apr-2025 IST. Sandu Pharmaceuticals Ltd has given a return of -10.05% in the last 3 years.
Sandu Pharmaceuticals Ltd has a market capitalisation of ₹ 52 Cr as on 24-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Sandu Pharmaceuticals Ltd is 1.24 times as on 24-Apr-2025, a 76% discount to its peers’ median range of 5.15 times.
The P/E ratio of Sandu Pharmaceuticals Ltd is 28.38 times as on 24-Apr-2025, a 34% discount to its peers’ median range of 43.02 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Sandu Pharmaceuticals Ltd and enter the required number of quantities and click on buy to purchase the shares of Sandu Pharmaceuticals Ltd.
Sandu Pharmaceuticals Limited manufactures and markets ayurvedic medicines under the SANDU brand in India and internationally. The company offers medicines in the areas of cardiovascular, endocrine, digestive, genito-urinary, muscular-skeletal, nervous, male reproductive, and respiratory system. It also provides medicines for gynecological; nutrition; skin; and ear, nose, and throat disorders. The company was founded in 1899 and is based in Mumbai, India.
The prominent promoters of Sandu Pharmaceuticals Ltd. are
| Name of promoters | Holding percentage |
|---|---|
|
UMESH BHASKAR SANDU |
14.37%
|
|
SHASHANK BHASKAR SANDU |
14.17%
|
|
JAYSHREE BHASKAR SANDU |
7.63%
|
|
AKSHATH FINVEST AND PROPERTIES PRIVATE LIMITED |
5.12%
|
The chairman of the company is Balram Viswanathan, and the managing director is .
There is no promoter pledging in Sandu Pharmaceuticals Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
5,597
|
|
|
396
|
|
|
219
|
|
|
118
|
| Sandu Pharmaceuticals Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
4.46
|
|
Operating margin(%)
|
3.21
|
|
Net Margin(%)
|
2.63
|
|
Dividend yield(%)
|
1.5
|
Yes, TTM profit after tax of Sandu Pharmaceuticals Ltd was ₹2 Cr.
₹-0.74
(
